Ganglion sentinelle envahi : faut-il faire le curage ou pas ? Essai randomisé SERC
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Reference38 articles.
1. Veille bibliographique et recommandation. Chirurgie du sein et axillaire. RPC Nice-Saint-Paul de Vence 2011;Barranger;Oncology,2011
2. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomized phase 3 trial;Krag;Lancet Oncol,2010
3. Years follow-up after sentinel lymph node quality of life at 2 biopsy, immediate or delayed axillary dissection for breast cancer;Al Nakib;Breast J,2010
4. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer;Fleissig;Breast Cancer Res Treat,2006
5. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial;Del Bianco;Eur J Surg Oncol,2008
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel nomogram and survival analysis for different lymph node status in breast cancer based on the SEER database;Breast Cancer;2024-05-27
2. Does Breast Surgery Type Alter Incidental Axillary Irradiation? A Dosimetric Analysis of the “Sentinel Envahi et Randomisation du Curage” SERC Trial;Cancers;2024-03-19
3. The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases;Cancer Medicine;2022-09-20
4. Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort;Bulletin du Cancer;2021-11
5. St. Gallen 2021 Chinese expert perspective of optimal regional management;Translational Breast Cancer Research;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3